Clinical trial · Observational
Lower Urinary Tract Symptoms After Intravesical Therapy
Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder
NCT05844059CI-TRIAL-00066150LUTSIunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapeutic Toxicity | — | UNRESOLVED | — |
| Chemotherapy Effect | — | UNRESOLVED | — |
| Lower Urinary Tract Symptoms | — | UNRESOLVED | — |
| Overactive Bladder | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Validated questionnaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients undergoing instillation therapy with BCG
- description
- All patients that undergo therapy with BCG after diagnosis of non-muscle-invasive bladder cancer
- interventionNames
- Other: Validated questionnaires
- label
- Patients undergoing instillation therapy with Mitomycin C
- description
- All patients that undergo therapy with Mitomycin C after diagnosis of non-muscle-invasive bladder cancer
- interventionNames
- Other: Validated questionnaires
Primary outcomes (3)
- measure
- Effect of instillation therapy on quality of life
- timeFrame
- During the study period approximately 12 months
- description
- Quality of life will be measured with validated questionnaires such as the ICIQ-OABqol
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Urinary bladder carcinoma requiring instillation therapy * Complete resection of the tumor * No intravesical chemotherapy in the last 3 months Exclusion Criteria: * Patients who are unable to complete the questionnaires * Patients who are not willing to participate * Patients with contraindications for instillation therapy (allergic reactions, immunosuppression)
References
Publications (0)
Data not yet available
No reference posted for this study.